logo-loader

Omega Diagnostics Group Plc

Receive alerts
Market:
AIM
Market Cap:
£16.31 m
Price
10.85 GBX
Change
-5.65%
52 weeks high
18.00
52 weeks low
8.19

In brief

Omega Diagnostics Group PLC is a United Kingdom-based holding company. The Company, along with its subsidiaries, is principally engaged in the manufacture, development and distribution of medical diagnostic products. On September 3, 2007, the Company acquired 100% of the voting shares of Genesis Diagnostics Ltd (Genesis) and Cambridge Nutritional Sciences Ltd (CNS). Genesis operates in the medical diagnostics industry developing, producing and selling a range of test kits specializing in the areas of autoimmune disease, infectious diseases and food intolerance. CNS provides a testing service for food intolerance and various other diseases.

Latest

RNS

Result of AGM

17 hours, 55 minutes ago
RNS

Holding(s) in Company

1 week, 1 day ago
RNS

Holding(s) in Company

1 week, 2 days ago
RNS

Holding(s) in Company

1 week, 2 days ago
RNS

Holding(s) in Company

1 week, 5 days ago
RNS

Result of General Meeting

1 week, 6 days ago